COLEMAN MARK 1658379 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-15 | 2023-09-15 | 2023-09-15 | 4 | Coleman Mark | DIRECTOR | dsp | 18572.0 | 4.4 | 3.94 | 75.18 | An Entity | Common Stock | AXSOME THERAPEUTICS, INC. | code S | 403856.0 | 47.19 (AXSM) |
| 2023-09-15 | 2023-09-15 | 2023-09-15 | 4 | Coleman Mark | DIRECTOR | dsp | 11016.0 | 30.5 | 2.33 | 75.19 | Direct | Common Stock | AXSOME THERAPEUTICS, INC. | code S | 25097.0 | 47.19 (AXSM) |
| 2023-09-15 | 2023-09-15 | 2023-09-15 | 4 | Coleman Mark | DIRECTOR | acq | 11016.0 | 30.5 | 2.33 | 3.67 | Direct | Common Stock | AXSOME THERAPEUTICS, INC. | code M | 36113.0 | 47.19 (AXSM) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-06 | 2023-06-02 | 2023-06-02 | 4 | Coleman Mark | DIRECTOR | acq | 5681.0 | 100.0 | 1.3 | 74.12 | Direct | Stock Option (Right To Buy) | AXSOME THERAPEUTICS, INC. | code A | 5681.0 | 43.57 (AXSM) |
| 2023-09-15 | 2023-09-15 | 2023-09-15 | 4 | Coleman Mark | DIRECTOR | dsp | 11016.0 | 100.0 | 2.33 | 3.67 | Direct | Stock Option (Right To Buy) | AXSOME THERAPEUTICS, INC. | code M | 0.0 | 47.19 (AXSM) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)